Finzati - Logo
KYMR logo

Kymera Therapeutics, Inc.

KYMR • Biotechnology
$117.39
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$11.53B
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.05Healthy liquidity · 10.47Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 12, 2026, 12:36 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$117.39
Change0.00%
Shares Out98.18M
Market Cap$11.53B
Enterprise Value$10.91B
52W Range37.57 - 130.05
Beta1.96
P/E-38.46
P/S109.77
P/B7.64
P/FCF-48.43
EV/Sales103.94

Investment DNA

How strong this company looks for long-term investors

33
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
44/100
Why this score▼
Manageable debt level · 0.05Healthy liquidity · 10.47Negative growth trendWeak profitability

Analyst view

Analyst sentiment and price target

KYMR
Analyst sentiment
Based on 27 analyst votes · 2026-09-05
93/100
Bullish
Bullish
23
Hold
4
Bearish
0
Price Target
2026-08-12
Low
$97.00
Mean
$129.64
Median
$135.00
High
$155.00

Company Overview

IPO: 8/21/2020
Industry: Biotechnology
P/B i: 7.64
Debt / Equity i: 0.05
Operating Margin: -891.33%
Net Margin: -794.39%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.05
Current Ratio: 10.47
Quick Ratio: 10.47
Status: Good

Insider Transactions

Recent executive and insider activity

Rooney Terence
Transaction: 07/27/2026
OTHER
Change
0
Price
Not reported
Filing
07/27/2026
Type
OTHER
Rooney Terence
Transaction: 07/27/2026
BUY
Change
+38,000
Price
Not reported
Filing
07/27/2026
Type
BUY
Rooney Terence
Transaction: 07/27/2026
BUY
Change
+76,000
Price
$110.05
Filing
07/27/2026
Type
BUY